首页> 美国卫生研究院文献>British Medical Journal >Specific therapeutic group age-sex related prescribing units (STAR-PUs): weightings for analysing general practices prescribing in England.
【2h】

Specific therapeutic group age-sex related prescribing units (STAR-PUs): weightings for analysing general practices prescribing in England.

机译:特定的治疗组与年龄性别有关的处方单位(STAR-PU):用于分析英格兰的一般惯例的处方的权重。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

OBJECTIVES--To derive cost comparators for prescribing by English general practitioners in eight specific therapeutic groups, based on age-sex related weightings, and to confirm, from a new dataset, earlier age-sex weightings for overall prescribing (ASTRO-PUs). DESIGN--Calculations based on one year's prescribing data from selected practices using AAH Meditel software, held on MediPlus by Intercontinental Medical Statistics (IMS, UK and Ireland), and research practices using VAMP software, held on the General Practice Research Database. SETTING--112 English practices with 739,672 patients and 510 British practices with 3,126,570 patients. MAIN OUTCOME MEASURES--Cost based weightings for 18 age-sex groups and for temporary residents for eight leading specific therapeutic groups and for prescribing overall. RESULTS--The two datasets were similar in age distribution and in the way that prescription numbers were distributed by age-sex band in each therapeutic group. The cost based weightings for specific therapeutic groups showed great variation in the use of these groups for patients in different age-sex groups. When these weightings were applied to the prescribing of practices in two family health services authorities they differed in their power to predict prescribing costs: for cardiovascular and gastrointestinal drugs predictive power was particularly high; for drugs for infections it was particularly low, since these are widely used at all ages and for both sexes. Cost based weightings for overall prescribing derived from the IMS data were similar to those of the ASTRO-PU system even though they were derived by different methods from different datasets. CONCLUSIONS--The weightings (STAR-PUs) offer a sound basis for cost comparisons at the therapeutic group level. Cost-based weightings for overall prescribing derived from the IMS data were reassuringly similar to those of the existing ASTRO-PU system.
机译:目标-根据年龄性别相关权重,得出费用比较器,以供英国全科医生在八个特定治疗组中开具处方,并从新数据集中确认较早的年龄性别总体开具权重(ASTRO-PU)。设计-基于使用AAH Meditel软件(由Intercontinental Medical Statistics(IMS,英国和爱尔兰)在MediPlus上持有)的选定实践的一年处方数据以及使用在通用实践研究数据库上持有的VAMP软件进行的研究计算得出。地点--112项英语练习共739,672名患者,510项英国练习共3,126,570名患者。主要观察指标-18个性别小组的临时加权成本以及八个主要治疗组的临时居民的总体加权成本。结果-这两个数据集的年龄分布以及每个治疗组中按年龄性别带分配处方数的方式相似。特定治疗组的基于成本的权重显示,这些组在不同年龄性别组的患者中的使用差异很大。当将这些权重应用于两个家庭保健服务机构的实践处方时,它们在预测处方费用方面的能力有所不同:对于心血管和胃肠道药物而言,预测能力特别高;由于用于感染的药物的使用率特别低,因为它们在各个年龄段和男女中都广泛使用。从IMS数据得出的基于总体处方的基于成本的权重与ASTRO-PU系统的相似,尽管它们是通过不同方法从不同的数据集中得出的。结论-权重(STAR-PU)为治疗组水平的成本比较提供了可靠的基础。从IMS数据得出的基于总处方的基于成本的权重确实与现有ASTRO-PU系统的权重相似。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号